These findings indicate that (1) drugs with PXR agonism elevate TC and LDL-C and that (2) increased cholesterol synthesis may play a role in drug-induced and PXR-mediated hypercholesterolemia. The gene discussed is NR1I2; the disease is familial hypercholesterolemia.